As economic/beneficial owner, Conventus is accountable for aspects regarding sponsoring, social evening events and the accompanying programme.


The member companies of the "Voluntary Self-Regulation of the Pharmaceutical Industry (FSA) eV" have more narrowly defined the FSA code to ensure more transparency.

In future, congress organisers are obliged to inform potential congress participants, in advance, about the scope and terms of the support of the pharmaceutical industry. We fulfil this obligation and therefore inform you about the amount of the sponsorship of companies involved:

Gilead Sciences GmbH 15.000,00 €, Associates of Cape Cod Europe GmbH 9.000,00 €, Pfizer Corporation Austria Gesellschaft m.b.H.10.000,00 €, Check Diagnostics GmbH 3.420,00 €, FUJIFILM Wako Chemicals Europe GmbH 10.000,00 €, EUROIMMUN Medizinische Labordiagnostika AG 1.710,00 €, Biomedica Medizinprodukte GmbH 1.710,00 €, PAUL HARTMANN Ges.m.b.H.1.200,00 €, Szabo-Scandic Handels GmbH 250,00 €, bioMerieux Austria GmbH 500,00 €, TECOMedical AG 2.010,00 €, Schülke + Mayr GmbH 1.500,00 €, IMMY 4.000,00 €